Zur Navigation springenZum Content springenLogin | Aktuelles | Impressum | Datenschutz
Logo
  • GRK2633
  • People
    • Doctoral researchers
    • Participating researchers
    • Early career researchers
    • Administration
    • RTG Persons of trust
    • Finished doctoral degrees
  • Projects
    • 1st Generation
    • 2nd Generation
  • Events
  • Publications
  • Contacts
GRK2633 | Defining and Targeting Autoimmune Pre-Disease
University of Lübeck - Defining and Targeting Autoimmune Pre-Disease - Projects - 2nd Generation - Medical doctoral researcher projects
Medical doctoral researcher projects
  • Projects
    • 1st Generation
    • 2nd Generation
      • A: Defining Autoimmune Pre-Disease
      • B: Targeting of Autoimmune Pre-Disease
      • Associated projects
      • Medical doctoral researcher projects
        • MD A21: Antibodies targeting angiotensin II type 1 receptor as a putative mediator of driving endothelial dysfunction
        • MD A23: Investigation of the association of pulmonary fibrosis with tumor-associated antigens and their autoantibodies in systemic sclerosis
        • MD A24: Unveiling PTX3: A novel biomarker in the pathogenesis and progression of bullous pemphigoid
        • MD B9: Testing substances influencing the protein biosynthesis in the human skin organ culture model for pemphigus vulgaris
        • MD B10: Testing ion channel inhibitors in the human skin organ culture model for pemphigus vulgaris
        • MD B13: Deciphering the signaling events in BP180 antibody-induced pathology to investigate possible impacts for the onset of new autoimmune reactions
        • MD B14: Selective depletion of antigen-specific autoantibodies by targeted degradation
      • Concluded projects

 

 

RTG 2633
Autoimmune Pre-Disease
University of Lübeck
Spokesperson: Ralf Ludwig